Genmab — April 2020

[E_L]

=463+474

[Bulder]

Nice

[E_L]

that is very very good

[E_L]

+49% j/j

[Bulder]

so row bigger than us?

[Sukkeralf]

wauuu

[E_L]

yes US 463

[Plimsoller]

No one-time revenue this time?

[Bulder]

kursen flintrer op

[E_L]

Genmab Announces Net Sales of DARZALEX® (daratumumab) for First Quarter of 2020

Company Announcement Net sales of DARZALEX® in the first quarter of 2020 totaled USD 937 millionGenmab will receive royalties on worldwide sales from...

GlobeNewswire News Room (www.globenewswire.com)

[Bulder]

Så er der lidt at give af på corona-kontoen ved q2

[E_L]

No, no No one-time issues it seems this time

[Plimsoller]

Thanks E L. That's quite important

[E_L]

yes lol

[E_L]

JNJ
CFO on CNBC now

[AaBforever]

STÆRKT!!:-)

[troldmanden]

Det er faktisk overraskende flot. Når Jan direkte har været ude at forberede marekdet på en mulig nedjustering af salgs forventninger

[Plimsoller]

Det kan være at han er begyndt at gøre tingene omvendt

[JørgenVarnæs]

kig igen på de US tal...

[E_L]

would be interesting to find out where the strong ROW growth came from: 71% j/j AND a 5.9% translation effect would have made it even bigger (currency effect), 77% operational growth...